Enarodustat (JTZ-951) - Moligand™, ≥98% , Egl nine homolog 1 inhibitor, CAS No.1262132-81-9, Egl nine homolog 1 inhibitor

CAS: 1262132-81-9 Cat. No.: E414445 Fórmula: C17H16N4O4 Peso molecular: 340.33
Disponible para pedir
CALIDAD & PUREZA Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥98%
Synonyms
Glycine, N-((7-hydroxy-5-(2-phenylethyl)(1,2,4)triazolo(1,5-a)pyridin-8-yl)carbonyl)-|Enarodustat (JTZ-951)|JTZ 951|2-(7-Hydroxy-5-phenethyl-[1,2,4]triazolo[1,5-a]pyridine-8-carboxamido)acetic acid|ENARODUSTAT [JAN]|(7-Hydroxy-5-phenethyl-[1,2,4]triazolo[1,5-a]pyridine-8-carbonyl)glycine|ENARODUSTAT [WHO-DD]|2-[[7-oxo-5-(2-phenylethyl)-3H-[1,2,4]triazolo[1,5-a]pyridine-8-carbonyl]amino]acetic acid|2-{[7-oxo-5-(2-phenylethyl)-3H,7H-[1,2,4]triazolo[1,5-a]pyridin-8-yl]formamido}acetic acid|Enarodustat|RIMANTADINE HYDROCHLORIDE [USP MONOGRAPH]|Fludroxycortidum (INN-Latin)|3-bromanyl-2,2-bis(bromomethyl)propan-1-ol|Enaroy|Enarodustat [INN]|N-((7-Hydroxy-5-(2-phenylethyl)(1,2,4)triazolo(1,5-a)pyridin-8-yl)carbonyl)glycine|JTZ951|JTZ-951
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Talla
Alemania (EU)
USA*
Precio
Cantidad
5mg
E414445-5mg
—
3 Disponible

34,62€

51,98€
Guardar 17,35 € (33.39%)
10mg
E414445-10mg
—
2 Disponible

61,52€

92,76€
Guardar 31,24 € (33.68%)
25mg
E414445-25mg
—
1 Disponible

133,55€

200,36€
Guardar 66,82 € (33.35%)
50mg
E414445-50mg
—
1 Disponible

227,26€

340,93€
Guardar 113,67 € (33.34%)
100mg
E414445-100mg
—
1 Disponible

386,92€

580,43€
Guardar 193,51 € (33.34%)
Enter a quantity for the sizes you want to add.

Descripción general

Information

Enarodustat (JTZ-951) Enarodustat (JTZ-951) is a potent and orally active HIF prolyl hydroxylase inhibitor with IC50 of 0.22 μM for PHD2 and EC50 of 5.7 μM for EPO release from Hep3B cells. Enarodustat has the potential for the treatment of renal anemia.


Targets

PHD2 (Cell-free assay); EPO release from Hep3B cells (Cell-based assay) 0.22 μM; 5.7 μM(EC50)


In vitro

Enarodustat (JTZ-951) inhibits PHD2 with IC50 of 0.22 μM and the EPO release from Hep3B cells with EC50 of 5.7 μM.


In vivo

JTZ-951 (compound 14), with a 5-phenethyl substituent on the triazolopyridine group, increases hemoglobin levels with daily oral dosing in rats. JTZ-951 is rapidly absorbed after oral administration and disappears shortly thereafter, which can be advantageous in terms of safety. JTZ-951 is selected as a clinical candidate.


Cell Research(from reference)

Cell lines:Hep3B cells 

Incubation Time:24 h 

Especificaciones

Sinónimos
Glycine, N-((7-hydroxy-5-(2-phenylethyl)(1,2,4)triazolo(1,5-a)pyridin-8-yl)carbonyl)- | Enarodustat (JTZ-951) | JTZ 951 | 2-(7-Hydroxy-5-phenethyl-[1,2,4]triazolo[1,5-a]pyridine-8-carboxamido)acetic acid | ENARODUSTAT [JAN] | (7-Hydroxy-5-phenethyl-[1,2,4]triazolo[1,5-a]pyridine-8-carbonyl)glycine | ENARODUSTAT [WHO-DD] | 2-[[7-oxo-5-(2-p Show more
Especificaciones y pureza
Moligand™, ≥98%
Mecanismos bioquímicos y fisiológicos
Enarodustat (JTZ-951) is a potent and orally active HIF prolyl hydroxylase inhibitor with IC50 of 0.22 μM for PHD2 and EC50 of 5.7 μM for EPO release from Hep3B cells. Enarodustat has the potential for the treatment of renal anemia.
Condiciones de almacenamiento de almacenamiento
Store at -20°C
Enviado en
Ice chest + Ice pads
Este producto requiere envío en cadena de frío. Los servicios terrestres y otros servicios económicos no están disponibles.
Grado
Moligand™
Tipo de acción
INHIBITOR
Mecanismo de acción
Egl nine homolog 1 inhibitor
Pureza
≥98%
Propiedades del producto
ALogP
1.511
hba_count
4
Recuento HBD
2
Enlace rotable
6
Nombres e identificadores
Pubchem Sid
Pubchem Sid Url
https://pubchem.ncbi.nlm.nih.gov/substance/504770965
SMILES
C1=CC=C(C=C1)CCC2=CC(=O)C(=C3N2NC=N3)C(=O)NCC(=O)O
IUPAC Name
2-[[7-oxo-5-(2-phenylethyl)-3H-[1,2,4]triazolo[1,5-a]pyridine-8-carbonyl]amino]acetic acid
InChIKey
FJYRBJKWDXVHHO-UHFFFAOYSA-N
InChI
1S/C17H16N4O4/c22-13-8-12(7-6-11-4-2-1-3-5-11)21-16(19-10-20-21)15(13)17(25)18-9-14(23)24/h1-5,8,10H,6-7,9H2,(H,18,25)(H,19,20)(H,23,24)
Isómeros SMILES
C1=CC=C(C=C1)CCC2=CC(=O)C(=C3N2NC=N3)C(=O)NCC(=O)O
Peso molecular
340.33
Reaxys
50984607
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=50984607&ln=

Datos avanzados

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganic acids and derivatives
ClaseCarboxylic acids and derivatives
SubclassAmino acids, peptides, and analogues
Intermediate Tree Nodes Amino acids and derivatives - Alpha amino acids and derivatives - N-acyl-alpha amino acids and derivatives
Direct ParentN-acyl-alpha amino acids
Alternative Parents Triazolopyridines  Pyridinecarboxylic acids and derivatives  Benzene and substituted derivatives  Vinylogous amides  Triazoles  Heteroaromatic compounds  Secondary carboxylic acid amides  Cyclic ketones  Monocarboxylic acids and derivatives  Carboxylic acids  Azacyclic compounds  Organonitrogen compounds  Organic oxides  Hydrocarbon derivatives  
Molecular FrameworkAromatic heteropolycyclic compounds
Substituents N-acyl-alpha-amino acid - Pyridine carboxylic acid or derivatives - Triazolopyridine - Monocyclic benzene moiety - Pyridine - Benzenoid - Azole - Heteroaromatic compound - Vinylogous amide - 1,2,4-triazole - Carboxamide group - Cyclic ketone - Secondary carboxylic acid amide - Carboxylic acid - Monocarboxylic acid or derivatives - Azacycle - Organoheterocyclic compound - Hydrocarbon derivative - Organic nitrogen compound - Organic oxide - Organonitrogen compound - Organooxygen compound - Organic oxygen compound - Carbonyl group - Aromatic heteropolycyclic compound
DescripciónThis compound belongs to the class of organic compounds known as n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom.
External Descriptors Not available
Estructura 3D
Modelo de Estructura Química Interactiva





Objetivos asociados (humanos)
EGLN1 Tclin Egl nine homolog 1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
Certificados (CoA, COO, BSE/TSE y tabla de análisis)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

11 results found

Lot NumberCertificate TypeFechaArticulo
E2628138E2628138Certificate of AnalysisJun 05, 2026 E414445
F2307406F2307406Certificate of AnalysisMay 09, 2023 E414445
F2307407F2307407Certificate of AnalysisMay 09, 2023 E414445
F2307408F2307408Certificate of AnalysisMay 09, 2023 E414445
F2307409F2307409Certificate of AnalysisMay 09, 2023 E414445
F2307410F2307410Certificate of AnalysisMay 09, 2023 E414445
F2307411F2307411Certificate of AnalysisMay 09, 2023 E414445
F2307412F2307412Certificate of AnalysisMay 09, 2023 E414445
F2307413F2307413Certificate of AnalysisMay 09, 2023 E414445
F2307415F2307415Certificate of AnalysisMay 09, 2023 E414445
F2307416F2307416Certificate of AnalysisMay 09, 2023 E414445
Propiedades químicas y físicas
SolubilidadSolubility (25°C) In vitro DMSO: 68 mg/mL (199.8 mM); Ethanol: 2.5 mg/mL (7.34 mM); Water: Insoluble;
DMSO (mg/ml) Solubilidad máxima68
DMSO (mM) Solubilidad máxima199.806070578556
Agua (mg/ml) Solubilidad máxima<1
Peso molecular340.33
XLogP31.600
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count6
Rotatable Bond Count6
Exact Mass340.117 Da
Monoisotopic Mass340.117 Da
Topological Polar Surface Area111.000 Ų
Heavy Atom Count25
Formal Charge0
Complexity674.000
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Seguridad y peligros (GHS)
Reaxys
50984607
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=50984607&ln=
Calculadoras de soluciones
Reseñas

Reseñas de cliente

¿Quieres que te enviemos un mensaje cuando tengamos descuentos disponibles?

Recordármelo más tarde

¡Gracias! Por favor, revisa tu bandeja de entrada de correo electrónico para confirmar.

¡Vaya! Las notificaciones están desactivadas.